NASDAQ · Financial Statements

BIO-key International, Inc. (BKYI) Revenue, Earnings & Financial Statements

$1.94 NASDAQ: BKYI Market Cap $2.79M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

BIO-key International, Inc. most recently reported annual revenue of $6.0M, a net loss of $5.0M. Revenue grew at an average annual rate of 14.9% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

BIO-key International, Inc.: Revenue rose from $3.0M in 2016 to $6.0M in 2025, a change of +100.0% over 9 years; net profit was positive in 0 of 10 reported years; operating margin moved from -141.2% to -69.9%, a shift of +71.3 percentage points; the most recent year shows a net loss of $5.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$3.0M$6.0M$4.0M$2.0M$3.0M$5.0M$7.0M$8.0M$7.0M$6.0M
Operating Expenses$7.0M$11.0M$11.0M$16.0M$8.0M$10.0M$17.0M$17.0M$11.0M$10.0M
Operating Profit−$4.0M−$4.0M−$7.0M−$14.0M−$5.0M−$5.0M−$10.0M−$9.0M−$4.0M−$4.0M
Operating Margin-141.2%-67.8%-169.8%-596.2%-183.4%-96.6%-141.4%-113.8%-57.9%-69.9%
Other Income$0$0$0−$1.0M−$4.0M$0−$2.0M$0$0$0
Interest$0$0$0$1.0M$4.0M$0$0$0$0$0
Depreciation$0$2.0M$2.0M$1.0M$0$1.0M$1.0M$1.0M$0$0
Profit Before Tax−$4.0M−$4.0M−$7.0M−$15.0M−$10.0M−$5.0M−$12.0M−$9.0M−$4.0M−$5.0M
Tax rate (%)-0.0%0.0%0.0%0.0%0.0%0.0%0.2%1.6%0.5%0.4%
Net Profit−$4.0M−$4.0M−$7.0M−$15.0M−$10.0M−$5.0M−$12.0M−$9.0M−$4.0M−$5.0M
EPS−$1286.65−$1094.25−$1053.95−$1476.89−$226.64−$117.03−$272.65−$152.10−$20.88−$10.77

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$1.0M$2.0M$1.0M$2.0M$1.0M$2.0M$2.0M$2.0M$1.0M$2.0M$2.0M$1.0M
Operating Expenses$7.0M$3.0M$3.0M$3.0M$3.0M$2.0M$3.0M$2.0M$3.0M$2.0M$2.0M$2.0M
Operating Profit−$7.0M−$1.0M−$2.0M−$1.0M−$1.0M−$1.0M−$1.0M−$1.0M−$2.0M$0−$1.0M−$1.0M
Operating Margin-705.2%-23.3%-144.9%-27.1%-86.7%-39.9%-63.9%-57.6%-132.4%-5.5%-27.6%-55.3%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax−$6.0M−$1.0M−$2.0M−$1.0M−$1.0M−$1.0M−$1.0M−$1.0M−$2.0M$0−$1.0M−$1.0M
Tax rate (%)4.3%0.0%0.0%0.0%1.6%0.0%0.0%0.0%-1.0%0.0%0.0%0.0%
Net Profit−$6.0M−$1.0M−$2.0M−$1.0M−$2.0M−$1.0M−$1.0M−$1.0M−$2.0M$0−$1.0M−$1.0M
EPS−$116.15−$3.16−$10.02−$3.91−$5.17−$1.57−$2.01−$1.46−$1.85−$0.20−$0.56−$4.01

Over the 10 years reported for BIO-key International, Inc., cash stood at $3.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.67 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$17.0M$16.0M$12.0M$2.0M$23.0M$18.0M$11.0M$5.0M$9.0M$11.0M
Current Assets$5.0M$7.0M$4.0M$1.0M$19.0M$14.0M$9.0M$3.0M$2.0M$5.0M
Cash$1.0M$0$0$0$17.0M$8.0M$3.0M$1.0M$0$3.0M
Inventory$0$1.0M$1.0M$0$0$5.0M$4.0M$0$0$0
Receivables$2.0M$3.0M$2.0M$0$1.0M$1.0M$2.0M$1.0M$1.0M$1.0M
Fixed Assets$0$0$0$1.0M$1.0M$0$0$0$0$0
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$2.0M$1.0M$0$1.0M$1.0M$0$0$0$5.0M$5.0M
Other Assets$0$0$0$0$1.0M$1.0M$0$0$0$0
Total Liabilities$2.0M$2.0M$1.0M$5.0M$2.0M$2.0M$6.0M$3.0M$5.0M$3.0M
Current Liabilities$2.0M$2.0M$1.0M$4.0M$2.0M$2.0M$5.0M$3.0M$5.0M$3.0M
Borrowings$0$0$0$3.0M$1.0M$0$3.0M$0$2.0M$1.0M
Other Liabilities$2.0M$2.0M$1.0M$2.0M$1.0M$2.0M$3.0M$3.0M$3.0M$2.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$15.0M$14.0M$10.0M−$2.0M$20.0M$16.0M$5.0M$1.0M$4.0M$8.0M

For BIO-key International, Inc., operating cash flow was positive in 0 of 10 reported years; free cash flow in the latest year was negative at $5.0M; free cash flow was positive in 0 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow−$4.0M−$2.0M−$2.0M−$2.0M−$5.0M−$9.0M−$6.0M−$4.0M−$3.0M−$5.0M
Investing Cash Flow$0−$1.0M$0−$1.0M−$2.0M$0−$1.0M$0$0$0
Financing Cash Flow$0$1.0M$0$0$3.0M$0$0$0$0$0
Net Cash Flow−$3.0M−$1.0M$0$0$17.0M−$9.0M−$5.0M−$2.0M$0$2.0M
Free Cash Flow−$4.0M−$3.0M−$2.0M−$2.0M−$5.0M−$9.0M−$6.0M−$4.0M−$3.0M−$5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-0.34
FCF Yield-146.86%
Quick Ratio2.30
Interest Coverage-17.17
Return 1Y-78.14%
Return 3Y-92.64%
Return 5Y-99.55%

BIO-key International, Inc. (BKYI) financials — frequently asked questions

What is BIO-key International, Inc.'s annual revenue?

BIO-key International, Inc. (BKYI) reported annual revenue of $6.0M in its most recent fiscal year.

What is BIO-key International, Inc.'s net profit?

BIO-key International, Inc. (BKYI) reported a net loss of $5.0M in its most recent fiscal year.

What is BKYI EV/EBITDA?

BIO-key International, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.34. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Information Technology Services stocks

IBM revenue $67.5BACN revenue $74.2BFISV revenue $21.2BCTSH revenue $21.1BBR revenue $7.5BCDW revenue $22.4BWIT revenue $926.2BLDOS revenue $17.2BGIB revenue $16.6BFIS revenue $10.7BAll Information Technology Services stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Technology StocksLow P/E Technology StocksHigh Net Margin Technology StocksDividend Technology StocksLow Debt Technology StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
BKYI Overview BKYI Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.